Filing Details

Accession Number:
0001171843-14-005753
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-12-02 16:08:48
Reporting Period:
2014-12-01
Filing Date:
2014-12-02
Accepted Time:
2014-12-02 16:08:48
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
3116 Akorn Inc AKRX Pharmaceutical Preparations (2834) 720717400
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1466630 A Timothy Dick 1925 West Field Court Suite 300
Lake Forest IL 60045
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-12-01 61,111 $2.61 184,099 No 4 M Direct
Common Stock Disposition 2014-12-01 30,875 $39.23 153,224 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2014-12-01 61,111 $0.00 61,111 $2.61
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
122,223 2015-05-21 No 4 M Direct
Footnotes
  1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2014.
  2. Proceeds from the sale were used to pay exercise price and taxes due upon exercise of options.
  3. Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $38.57 to $39.92 per share. The reporting person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at separate prices within the foregoing range.
  4. Amount of Shares Beneficially Owned Following Reported Transaction includes 45,789 unvested shares subject to a restricted stock awards and 107,435 shares owned outright.
  5. The option vested in three annual installments with 122,222 options vesting on each of May 21, 2011 and May 21, 2012, and 122,223 options vesting on May 21, 2013.
  6. There was no consideration given in exchange for the security.